NDSS CGM Subsidy Initiative
The Australian Government provides access for eligible people to subsidised continuous glucose monitoring (CGM) products, including Guardian™ 4 Sensor through the NDSS (National Diabetes Services Scheme).
All people with type 1 diabetes are eligible to apply through the NDSS, as well as some people with other rare conditions that are similar to type 1 diabetes.
How to apply for subsidised Guardian™ 4 Sensor
1. Check the eligibility here:
- Children and young people aged under 21 years with type 1 diabetes
- People with type 1 diabetes aged 21 years or older
- Women with type 1 diabetes who are actively planning pregnancy, pregnant, or immediately post-pregnancy
- Children and young people under 21 years with conditions very similar to type 1 diabetes who require insulin
2. Ask your healthcare professional to complete and submit the necessary forms on your behalf. The forms can be found here
Note: If this is your first time applying for Guardian™ 4 Sensor, ensure your healthcare professional selects ‘Yes’ for the question ‘Is a starter kit required?’
For more information on this process or eligibility, please contact NDSS directly on 1800 637 700.
Already using CGM but want to try Guardian™ 4 Sensor?
If you are already registered with NDSS and use CGM or Flash Monitoring, you can swap to Guardian™ 4 Sensor at any time. Simply complete the Update or Ceasing Form and contact your Healthcare Professional, who will submit it on your behalf.
What if I am not eligible for NDSS subsidy?
Medtronic has some subscription offers available to access Guardian™ 4 Sensor at a discounted price. You can learn more about these offers below.
Do you want to learn more?
If you want to know more, please request a call to our team.
This form takes less than 60 seconds to complete.
ALWAYS FOLLOW THE DIRECTIONS FOR USE.
The MiniMed 780G insulin pump is indicated for use by patients age 7-80 years with Type 1 diabetes, whose total daily dose of insulin is 8 units per day or more. The MiniMed 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to provide an automatic adjustment of insulin delivery based on continuous glucose monitoring (CGM) and can suspend the delivery of insulin when the SG value falls below, or is predicted to fall below, predefined threshold values.
The Guardian 4 sensor is intended for use with the Guardian 4 transmitter to monitor glucose levels in persons with diabetes where self-monitoring of blood glucose (SMBG) is indicated. The sensor is designed to replace fingerstick blood glucose (BG)readings for diabetes treatment decisions. The sensor is intended for insertion into persons ages 7 years and older. The sensor is intended for insertion into the back of the upper arm or the upper buttocks in persons ages 7 through 17 years. The sensor is intended for insertion into the back of the upper arm or the abdomen in persons ages 18 years and older.
12677-052023 ©2023 Medtronic. All rights reserved Medtronic.